SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-23-004016
Filing Date
2023-06-08
Accepted
2023-06-08 17:00:57
Documents
18

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT phio_s1.htm   iXBRL S-1 299547
2 ATTORNEY OPINION AND CONSENT phio_ex0501.htm EX-5.1 7631
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_ex2301.htm EX-23.1 2861
4 CALCULATION OF FILING FEE TABLES phio_ex107.htm EX-FILING FEES 41918
5 GRAPHIC image_001.jpg GRAPHIC 2554
6 GRAPHIC image_002.jpg GRAPHIC 3048
7 GRAPHIC image_003.jpg GRAPHIC 2231
  Complete submission text file 0001683168-23-004016.txt   582689

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE phio-20230608.xsd EX-101.SCH 2947
9 XBRL LABEL FILE phio-20230608_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE phio-20230608_pre.xml EX-101.PRE 22351
12 EXTRACTED XBRL INSTANCE DOCUMENT phio_s1_htm.xml XML 2849
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-272526 | Film No.: 231002749
SIC: 2834 Pharmaceutical Preparations